146 related articles for article (PubMed ID: 35473348)
1. Effectiveness and safety of red yeast rice predominated by monacolin K β-hydroxy acid form for hyperlipidemia treatment and management.
Benjian C; Xiaodan H; Huiting P; Yishi LI; Yongtao C; Huanlin WU; Danping XU
J Tradit Chin Med; 2022 Apr; 42(2):264-271. PubMed ID: 35473348
[TBL] [Abstract][Full Text] [Related]
2. Low Dose Monacolin K Combined with Coenzyme Q10, Grape Seed, and Olive Leaf Extracts Lowers LDL Cholesterol in Patients with Mild Dyslipidemia: A Multicenter, Randomized Controlled Trial.
Angelopoulos N; Paparodis RD; Androulakis I; Boniakos A; Argyrakopoulou G; Livadas S
Nutrients; 2023 Jun; 15(12):. PubMed ID: 37375586
[TBL] [Abstract][Full Text] [Related]
3. LDL-cholesterol lowering effect of a new dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate hypercholesterolemia.
Magno S; Ceccarini G; Pelosini C; Jaccheri R; Vitti J; Fierabracci P; Salvetti G; Airoldi G; Minale M; Saponati G; Santini F
Lipids Health Dis; 2018 May; 17(1):124. PubMed ID: 29793488
[TBL] [Abstract][Full Text] [Related]
4. Nutraceutical approach for the management of cardiovascular risk - a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study.
Ruscica M; Pavanello C; Gandini S; Macchi C; Botta M; Dall'Orto D; Del Puppo M; Bertolotti M; Bosisio R; Mombelli G; Sirtori CR; Calabresi L; Magni P
Nutr J; 2019 Feb; 18(1):13. PubMed ID: 30795775
[TBL] [Abstract][Full Text] [Related]
5. A Randomized Clinical Efficacy Trial of Red Yeast Rice (Monascus pilosus) Against Hyperlipidemia.
Wang TJ; Lien AS; Chen JL; Lin CH; Yang YS; Yang SH
Am J Chin Med; 2019; 47(2):323-335. PubMed ID: 30871361
[TBL] [Abstract][Full Text] [Related]
6. Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter Study.
Cicero AF; Derosa G; Pisciotta L; Barbagallo C;
J Med Food; 2015 Nov; 18(11):1270-3. PubMed ID: 26274827
[TBL] [Abstract][Full Text] [Related]
7. Low dose red yeast rice with monacolin K lowers LDL cholesterol and blood pressure in Japanese with mild dyslipidemia: A multicenter, randomized trial.
Minamizuka T; Koshizaka M; Shoji M; Yamaga M; Hayashi A; Ide K; Ide S; Kitamoto T; Sakamoto K; Hattori A; Ishikawa T; Kobayashi J; Maezawa Y; Kobayashi K; Takemoto M; Inagaki M; Endo A; Yokote K
Asia Pac J Clin Nutr; 2021 Sep; 30(3):424-435. PubMed ID: 34587702
[TBL] [Abstract][Full Text] [Related]
8. In vivo hypolipidemic effects and safety of low dosage Monascus powder in a hamster model of hyperlipidemia.
Lee CL; Tsai TY; Wang JJ; Pan TM
Appl Microbiol Biotechnol; 2006 May; 70(5):533-40. PubMed ID: 16283302
[TBL] [Abstract][Full Text] [Related]
9. Relationship between adiponectin and leptin, and blood lipids in hyperlipidemia patients treated with red yeast rice.
Lee CY; Jan MS; Yu MC; Lin CC; Wei JC; Shih HC
Forsch Komplementmed; 2013; 20(3):197-203. PubMed ID: 23860021
[TBL] [Abstract][Full Text] [Related]
10. ESSENS dyslipidemia: A placebo-controlled, randomized study of a nutritional supplement containing red yeast rice in subjects with newly diagnosed dyslipidemia.
Kasliwal RR; Bansal M; Gupta R; Shah S; Dani S; Oomman A; Pai V; Prasad GM; Singhvi S; Patel J; Sivam S; Trehan N
Nutrition; 2016; 32(7-8):767-76. PubMed ID: 27143594
[TBL] [Abstract][Full Text] [Related]
11. Low daily dose of 3 mg monacolin K from RYR reduces the concentration of LDL-C in a randomized, placebo-controlled intervention.
Heinz T; Schuchardt JP; Möller K; Hadji P; Hahn A
Nutr Res; 2016 Oct; 36(10):1162-1170. PubMed ID: 27865358
[TBL] [Abstract][Full Text] [Related]
12. The short-term supplementation of monacolin K improves the lipid and metabolic patterns of hypertensive and hypercholesterolemic subjects at low cardiovascular risk.
Mazza A; Schiavon L; Rigatelli G; Torin G; Montanaro F; Lenti S
Food Funct; 2018 Jul; 9(7):3845-3852. PubMed ID: 29951651
[TBL] [Abstract][Full Text] [Related]
13. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study.
Hobbs T; Caso R; McMahon D; Nymark M
Altern Ther Health Med; 2014; 20(5):18-23. PubMed ID: 25141367
[TBL] [Abstract][Full Text] [Related]
14. Red Yeast Rice for Hypercholesterolemia.
Cicero AFG; Fogacci F; Banach M
Methodist Debakey Cardiovasc J; 2019; 15(3):192-199. PubMed ID: 31687098
[TBL] [Abstract][Full Text] [Related]
15. Red Yeast Rice for Hypercholesterolemia: JACC Focus Seminar.
Cicero AFG; Fogacci F; Zambon A
J Am Coll Cardiol; 2021 Feb; 77(5):620-628. PubMed ID: 33538260
[TBL] [Abstract][Full Text] [Related]
16. [Red yeast rice, monacolin K, and pleiotropic effects.].
Cicero AFG
Recenti Prog Med; 2018 Feb; 109(2):154e-157e. PubMed ID: 29493648
[TBL] [Abstract][Full Text] [Related]
17. [Intervention of Huayu Qutan Recipe on liver SREBP-2 signal pathway of hyperlipidemia rats of pi deficiency syndrome].
Leng X; Jia LQ; Yang GL; Wang JY; Zhu ML; Wang Y; Xu Y
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Mar; 35(3):320-6. PubMed ID: 25951638
[TBL] [Abstract][Full Text] [Related]
18. [Effects of lovastatin and probucol on lipoprotein fractions in patients with hypercholesterolemia. A Brazilian multicenter study].
Forti N; Ramires JA
Arq Bras Cardiol; 1991 Sep; 57(3):253-61. PubMed ID: 1824203
[TBL] [Abstract][Full Text] [Related]
19. Monacolin K supplementation in patients with hypercholesterolemia: A systematic review of clinical trials.
Liasi E; Kantilafti M; Hadjimbei E; Chrysostomou S
Semergen; 2024; 50(4):102156. PubMed ID: 38310834
[TBL] [Abstract][Full Text] [Related]
20. Effects of Xuezhikang in patients with dyslipidemia: a multicenter, randomized, placebo-controlled study.
Moriarty PM; Roth EM; Karns A; Ye P; Zhao SP; Liao Y; Capuzzi DM; Bays HE; Zhang F; Liu S; Reichman AJ; Brusco OA; Lu G; Lerman S; Duan Z; Guo S; Liu PL; Zhao J; Zhang Y; Li S
J Clin Lipidol; 2014; 8(6):568-575. PubMed ID: 25499939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
